Clinical Evaluation of Safety and Efficacy of a Central Current Good Manufacturing Practices Laboratory Produced Autologous Adipose-Derived Stromal Vascular Fraction Cell Therapy Product for the Treatment of Knee Osteoarthritis-Reference-Cited by-同舟云学术

Clinical Evaluation of Safety and Efficacy of a Central Current Good Manufacturing Practices Laboratory Produced Autologous Adipose-Derived Stromal Vascular Fraction Cell Therapy Product for the Treatment of Knee Osteoarthritis

Published:2024-04-01 Issue:7-8 Volume:33 Page:168-176
ISSN:1547-3287
Container-title:Stem Cells and Development
language:en
Short-container-title:Stem Cells and Development

Author:

Rogers Christopher J.¹,Harman Robert²^ORCID,Sheinkop Mitchell B.³,Hanson Peter⁴,Ambach Mary A.¹,David Tal⁵,Desai Rahul⁶,Sampson Steven⁷,Aufierro Danielle⁷,Bowen Jay⁸,Malanga Gerard⁸

Affiliation:

1. San Diego Orthobiologics Medical Group, Carlsbad, California, USA.

2. Personalized Stem Cells, Poway, California, USA.

3. Cellular Orthopedics, Chicago, Illinois, USA.

4. Grossmont Orthopedic Medical Group, La Mesa, California, USA.

5. Synergy Orthopedics Specialist Group, San Diego, California, USA.

6. Restore PDX, Beaverton, Oregon, USA.

7. Ortho Healing Center, Los Angeles, California, USA.

8. New Jersey Regenerative Institute, Cedar Knolls, New Jersey, USA.

Publisher

Mary Ann Liebert Inc

Link

https://www.liebertpub.com/doi/pdf/10.1089/scd.2024.0008

Reference57 articles.

1. Osteoarthritis: New Insights. Part 1: The Disease and Its Risk Factors

2. Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010

3. Updated Projected Prevalence of Self-Reported Doctor-Diagnosed Arthritis and Arthritis-Attributable Activity Limitation Among US Adults, 2015-2040

4. Osteoarthritis: A disease of the joint as an organ

5. Mesenchymal stem cells for cartilage repair in osteoarthritis